Craft

Genomic Tree

Stock Price

₩16.6 K

2024-10-29

Market Capitalization

₩403.8 B

2024-10-29

Revenue

₩2.4 B

FY, 2024

Genomic Tree Summary

Company Summary

Overview
Genomic Tree ((주)지노믹트리) is a biotechnology company that develops in-vitro molecular diagnostic products. It offers Earlytech, an early detection product for lung, colon, and bladder cancer, AccuraTect, a cancer companion diagnostic product, etc.
Type
Public
Status
Active
Founded
2000
Website
http://genomictree.com/ko/
Cybersecurity rating
Sectors

Table of Contents

Genomic Tree Financials

Summary Financials

Revenue (Q3, 2025)
₩896.8M
Gross profit (Q3, 2025)
₩320.1M
Net income (Q3, 2025)
(₩2.8B)
Cash (Q3, 2025)
₩16.1B
EBIT (Q3, 2025)
(₩3.3B)
Enterprise value
$389.9B

Footer menu